A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study Evaluating the Safety and Efficacy of Pirfenidone Solution for Inhalation (AP01) in Subjects with Progressive Pulmonary Fibrosis (PPF)

Project Details

StatusActive
Effective start/end date1/08/24 → 29/09/28

Funding

  • Syneos Health Australia: A$50,000.00